U-Blot® Research Grade BlisibimodCat. No. WA2536$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade BlisibimodCat. No. WA2536
U-Blot® Research Grade BlinatumomabCat. No. WA2535
U-Blot® Research Grade blidarvetugCat. No. WA2534
U-Blot® Research Grade BleselumabCat. No. WA2533
U-Blot® Research Grade BivatuzumabCat. No. WA2532
U-Blot® Research Grade BirtamimabCat. No. WA2531
U-Blot® Research Grade birinkibartCat. No. WA2530
U-Blot® Research Grade Bintrafusp AlfaCat. No. WA2529
U-Blot® Research Grade BimekizumabCat. No. WA2528
U-Blot® Research Grade BimagrumabCat. No. WA2527
U-Blot® Research Grade Bifikafusp AlfaCat. No. WA2526
U-Blot® Research Grade BifarceptCat. No. WA2525